OncoSec Medical Inc ONCS

NAS: ONCS | ISIN: US68234L3069 25/08/2023

0,000 USD (0,00%)

(0,00%) 25/08/2023

Grafiek OncoSec Medical Inc

Grafiek OncoSec Medical Inc

1 dag1d 0,00%
1 week1w 0,00%
1 maand1m 0,00%
3 maanden3m 0,00%
6 maanden6m 0,00%
1 jaar1j -99,97%
5 jaar5j -100,00%

OncoSec Medical Inc in het nieuws

Toon enkel gratis nieuws

18 mei 2023 · OncoSec Announces Closing of $1.33 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules · Persbericht

16 mei 2023 · OncoSec Announces $1.33 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules · Persbericht

16 mei 2023 · OncoSec is encouraged after FDA meeting to discuss proposed neoadjuvant melanoma clinical program · Persbericht

27 april 2023 · OncoSec Receives $3.49 Million to Strengthen its Balance Sheet After Selling its Net Operating Loss Tax Benefits Through The New Jersey Economic Development Authority NOL Program · Persbericht

11 april 2023 · OncoSec Announces Closing of $2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules · Persbericht

10 april 2023 · OncoSec Announces $2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules · Persbericht

3 april 2023 · OncoSec Announces Clinical Data of the KEYNOTE-695 Trial Assessing TAVO™-EP in Combination with KEYTRUDA® (pembrolizumab) in Patients with Advanced Melanoma Refractory to anti-PD-1 Treatment · Persbericht

5 december 2022 · OncoSec to Present at the RHK Capital Disruptive Growth Conference on December 6, 2022 · Persbericht

30 november 2022 · OncoSec Announces Pricing of $3.5 Million Public Offering · Persbericht

15 november 2022 · OncoSec presents encouraging early data with TAVO™-EP combined with nivolumab (Opdivo®) in neoadjuvant melanoma · Persbericht

Profiel OncoSec Medical Inc

Commerciële diensten

Diverse commerciële diensten

Fabricage van farmaceutische preparaten

Gezondheidszorg

Medische/verpleegkundige diensten

Website: oncosec.com

Hoofdzetel: Pennington, New Jersey Verenigde Staten

CEO: Daniel O'Connor

Werknemers: 46

Aandelen OncoSec Medical Inc

Effecten: 5,96 miljoen

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe